Adma Biologics (ADMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 29,349 | 16,985 | 22,761 | 10,661 | 7,178 |
| Cost of Goods | 39,504 | 42,195 | 29,164 | 6,361 | 4,312 |
| Gross Profit | -10,155 | -25,209 | -6,404 | 4,300 | 2,866 |
| Operating Expenses | 31,773 | 35,274 | 33,071 | 21,991 | 18,691 |
| Operating Income | -41,424 | -60,289 | -39,310 | -17,330 | -15,514 |
| Interest Expense | 8,993 | 5,523 | 3,286 | 2,240 | 1,843 |
| Other Income | 2,138 | 68 | -1,163 | 55 | -613 |
| Pre-tax Income | -48,279 | -65,743 | -43,759 | -19,515 | -17,970 |
| Net Income Continuous | -48,279 | -65,743 | -43,759 | -19,515 | -17,970 |
| Net Income | $-48,279 | $-65,743 | $-43,759 | $-19,515 | $-17,970 |
| EPS Basic Total Ops | -0.89 | -1.45 | -1.91 | -1.61 | -1.73 |
| EPS Basic Continuous Ops | -0.89 | -1.45 | -1.91 | -1.61 | -1.73 |
| EPS Diluted Total Ops | -0.89 | -1.45 | -1.91 | -1.61 | -1.73 |
| EPS Diluted Continuous Ops | -0.89 | -1.45 | -1.91 | -1.61 | -1.73 |
| EPS Diluted Before Non-Recurring Items | -0.92 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-37,129 | $-55,881 | $-35,979 | $-16,327 | $-14,778 |